Additionally, the association of σ2R/TMEM97 with proliferation indicates that the σ2R-selective in vivo radioligand imaging agent 18F-ISO-1 may be a useful marker for breast cancer imaging that could have utility in targeted cell-cycle therapy selection and evaluating response to therapy. Here, TMEM97 is linked to breast cancer.